title: The action of interleukin 6 and leukaemia inhibitory factor on liver cells.
abstract: The hepatic action of cytokines has generally been analysed in terms of the acute-phase response of the liver. The qualitative and quantitative changes in the expression of plasma proteins serve as defining criteria for cytokine function. Interleukin 6 (IL-6) and leukaemia inhibitory factor (LIF) are representatives of a group of cytokines which display strikingly similar effects in both human and rodent liver cells. Hallmarks of the action of these cytokines are the stimulation of type 2 acute-phase plasma proteins and enhancement of the effect of interleukin 1 (IL-1) or tumour necrosis factor alpha (TNF-alpha) on type 1 acute-phase plasma proteins. The transcriptional activation of the various acute-phase plasma protein genes involves common cis-acting regulatory elements whose sequences and location relative to the transcription start site vary from gene to gene. The activity of the IL-6- and LIF-responsive genes depends in part on transcription factors including several members of the C/EBP family, JunB and the glucocorticoid receptor. The expression of these transcription factors is in turn under cytokine-specific control. In a few cases, expression is temporally correlated with the activation of 'late' acute-phase protein genes. The finding that structurally distinct cytokines interact with separate receptors but elicit an almost identical liver cell response demands a reassessment of the contribution of each factor to the in vivo acute-phase response.
authors.affiliation: Department of Molecular and Cellular Biology, Roswell Park Cancer Institute, Buffalo, New York 14263.
authors.forename: H
authors.initials: H
authors.lastname: Baumann
authors.forename: S
authors.initials: S
authors.lastname: Marinkovic-Pajovic
authors.forename: K A
authors.initials: KA
authors.lastname: Won
authors.forename: V E
authors.initials: VE
authors.lastname: Jones
authors.forename: S P
authors.initials: SP
authors.lastname: Campos
authors.forename: G P
authors.initials: GP
authors.lastname: Jahreis
authors.forename: K K
authors.initials: KK
authors.lastname: Morella
mesh_terms: D000818:Animals; D001798:Blood Proteins / Q000187:drug effects; D002460:Cell Line; D006131:Growth Inhibitors / Q000494:pharmacology*; D015850:Interleukin-6 / Q000494:pharmacology*; D053605:Leukemia Inhibitory Factor; D008099:Liver / Q000166:cytology / Q000187:drug effects*; D008222:Lymphokines / Q000494:pharmacology*; D012333:RNA, Messenger / Q000187:drug effects; D014157:Transcription Factors / Q000235:genetics; D014158:Transcription, Genetic / Q000187:drug effects
chemical_list: D001798:Blood Proteins; D006131:Growth Inhibitors; D015850:Interleukin-6; C507837:LIF protein, human; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines; D012333:RNA, Messenger; D014157:Transcription Factors